2007
DOI: 10.1158/0008-5472.can-06-2164
|View full text |Cite
|
Sign up to set email alerts
|

Adamantyl-Substituted Retinoid-Related Molecules Bind Small Heterodimer Partner and Modulate the Sin3A Repressor

Abstract: Numerous mechanisms have been proposed for how these compounds exert this effect. This report shows that AHPN/ 3-Cl-AHPC binds specifically to the orphan nuclear receptor small heterodimer partner (SHP; NR0B2), and this binding promotes interaction of the receptor with a corepressor complex that minimally contains Sin3A, N-CoR, histone deacetylase 4, and HSP90. Formation of the SHP-Sin3A complex is essential for the ability of AHPN and 3-Cl-AHPC to induce apoptosis, as both knockout SHP and knockdown of Sin3A … Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
104
2

Year Published

2007
2007
2015
2015

Publication Types

Select...
6
2

Relationship

2
6

Authors

Journals

citations
Cited by 70 publications
(107 citation statements)
references
References 44 publications
1
104
2
Order By: Relevance
“…Indeed, recent reports indicate that SHP associates with N-CoR in vivo despite the absence of a physical interaction (21) and that binding of adamantyl-substituted retinoid-related molecules to SHP results in the recruitment of N-CoR and GPS2-containing corepressor complexes (23).…”
Section: Resultsmentioning
confidence: 99%
“…Indeed, recent reports indicate that SHP associates with N-CoR in vivo despite the absence of a physical interaction (21) and that binding of adamantyl-substituted retinoid-related molecules to SHP results in the recruitment of N-CoR and GPS2-containing corepressor complexes (23).…”
Section: Resultsmentioning
confidence: 99%
“…Whereas some of the ARRs such as 6-[3′-(1-adamantyl)-4′-hydroxyphenyl]-2-naphthalenecarboxylic acid (CD437/AHPN) may bind to certain nuclear retinoic acid receptors and several may activate this receptor, retinoic acid receptor binding and activation do not seem to play any role in their induction of cell death (24)(25)(26). We have recently discovered that the ARRs specifically bind to the small heterodimer partner SHP (27). In turn, ARR binding of SHP led to Sin3A/SHP complex formation, resulting in modification of the Sin3A complex members as well enhancement of Sin3A-associated HDAC activity (27).…”
Section: Introductionmentioning
confidence: 99%
“…We have recently discovered that the ARRs specifically bind to the small heterodimer partner SHP (27). In turn, ARR binding of SHP led to Sin3A/SHP complex formation, resulting in modification of the Sin3A complex members as well enhancement of Sin3A-associated HDAC activity (27). Although SHP binding to the ARRs and the recruitment of SHP/ARR to Sin3A are clear, the role of SHP, if any, in the modification of a Sin3A complex and enhancement of Sin3A-associated HDAC activity remains to be delineated.…”
Section: Introductionmentioning
confidence: 99%
“…Interestingly, synthetic retinoidlike compounds such as 3-Cl-AHPC have been shown to bind and regulate SHP activity (34)(35)(36). We speculate that binding of these pharmacophores might rearrange the kinked helix H10, thus allowing formation of the AF-2 cofactor-binding pocket.…”
Section: Arillmastlknipgtllvdlffrpimgdvditelledmlllr-aelnsalfllrfinsdmentioning
confidence: 93%
“…SHP-mediated repression is abolished in mice lacking FGF15, leading to abnormally high levels of CYP7A1 expression and fecal bile acid excretion (33). A number of retinoid-like compounds have been shown to bind to SHP and enhance its repression of CYP7A1 and CYP8B1 in liver cells (34)(35)(36). These findings underscore the importance of understanding the functional and structural basis for SHP's inhibitory function, which could serve as a drug target for treating metabolic diseases arising from bile acid and cholesterol imbalances.…”
Section: Significancementioning
confidence: 99%